BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1099 related articles for article (PubMed ID: 27344969)

  • 1. Reactive oxygen and nitrogen species in patients with rheumatoid arthritis as potential biomarkers for disease activity and the role of antioxidants.
    Khojah HM; Ahmed S; Abdel-Rahman MS; Hamza AB
    Free Radic Biol Med; 2016 Aug; 97():285-291. PubMed ID: 27344969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Serum Levels of Reactive Oxygen and Nitrogen Species on the Disease Severity of COVID-19.
    Ahmed SA; Alahmadi YM; Abdou YA
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of reactive oxygen and nitrogen species in etiopathogenesis of rheumatoid arthritis.
    Bauerová K; Bezek A
    Gen Physiol Biophys; 1999 Oct; 18 Spec No():15-20. PubMed ID: 10703714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin K homologs as potential biomarkers for disease activity in patients with rheumatoid arthritis.
    Khojah HM; Ahmed S; Abdel-Rahman MS; Alkhalil KM; Hamza AB
    J Bone Miner Metab; 2017 Sep; 35(5):529-535. PubMed ID: 27722902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab equivalently suppresses oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis.
    Kizaki K; Yamashita F; Hayashi T; Funakoshi N
    Int J Rheum Dis; 2018 Oct; 21(10):1815-1821. PubMed ID: 27778459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress in inflammatory cells of patient with rheumatoid arthritis: clinical efficacy of dietary antioxidants.
    Bala A; Mondal C; Haldar PK; Khandelwal B
    Inflammopharmacology; 2017 Dec; 25(6):595-607. PubMed ID: 28929423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of clinical parameters associated with serum oxidative stress in patients with rheumatoid arthritis.
    Nakajima A; Aoki Y; Shibata Y; Sonobe M; Terajima F; Takahashi H; Saito M; Taniguchi S; Yamada M; Nakagawa K
    Mod Rheumatol; 2014 Nov; 24(6):926-30. PubMed ID: 24670128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum matrix metalloproteinase 3 in early rheumatoid arthritis is correlated with disease activity and radiological progression.
    Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
    J Rheumatol; 2000 Dec; 27(12):2761-8. PubMed ID: 11128661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity.
    Arntz OJ; Pieters BCH; Thurlings RM; Wenink MH; van Lent PLEM; Koenders MI; van den Hoogen FHJ; van der Kraan PM; van de Loo FAJ
    Front Immunol; 2018; 9():2388. PubMed ID: 30420853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-3 levels in relation to disease activity and radiological progression in rheumatoid arthritis.
    Tuncer T; Kaya A; Gulkesen A; Kal GA; Kaman D; Akgol G
    Adv Clin Exp Med; 2019 May; 28(5):665-670. PubMed ID: 30740946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum matrix metalloproteinase 3 levels in comparison to C-reactive protein in periods with and without progression of radiological damage in patients with early rheumatoid arthritis.
    Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
    Clin Exp Rheumatol; 2003; 21(4):465-72. PubMed ID: 12942698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pomegranate extract alleviates disease activity and some blood biomarkers of inflammation and oxidative stress in Rheumatoid Arthritis patients.
    Ghavipour M; Sotoudeh G; Tavakoli E; Mowla K; Hasanzadeh J; Mazloom Z
    Eur J Clin Nutr; 2017 Jan; 71(1):92-96. PubMed ID: 27577177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROS and RNS in plant physiology: an overview.
    Del Río LA
    J Exp Bot; 2015 May; 66(10):2827-37. PubMed ID: 25873662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APRIL Level as a Marker of Disease Activity in Treated Rheumatoid Arthritis Patients: Association with Disease Activity and Anti-CCP Antibody.
    Boghdadi G; El-Sokkary RH; Elewa EA; Abbas SF
    Egypt J Immunol; 2015 Jun; 22(2):31-39. PubMed ID: 28502142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menaquinone-7 as a novel pharmacological therapy in the treatment of rheumatoid arthritis: A clinical study.
    Abdel-Rahman MS; Alkady EA; Ahmed S
    Eur J Pharmacol; 2015 Aug; 761():273-8. PubMed ID: 26073022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline serum level of matrix metalloproteinase-3 as a biomarker of progressive joint damage in rheumatoid arthritis patients.
    Galil SM; El-Shafey AM; Hagrass HA; Fawzy F; Sammak AE
    Int J Rheum Dis; 2016 Apr; 19(4):377-84. PubMed ID: 25292349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and predictive value of anti-cyclic citrullinated protein antibodies for future development of rheumatoid arthritis in early undifferentiated arthritis.
    Emad Y; Shehata M; Ragab Y; Saad A; Hamza H; Abou-Zeid A
    Mod Rheumatol; 2010 Aug; 20(4):358-65. PubMed ID: 20364358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement and meaning of markers of reactive species of oxygen, nitrogen and sulfur in healthy human subjects and patients with inflammatory joint disease.
    Winyard PG; Ryan B; Eggleton P; Nissim A; Taylor E; Lo Faro ML; Burkholz T; Szabó-Taylor KE; Fox B; Viner N; Haigh RC; Benjamin N; Jones AM; Whiteman M
    Biochem Soc Trans; 2011 Oct; 39(5):1226-32. PubMed ID: 21936794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic antioxidant and anti-inflammatory effects of laser acupuncture on patients with rheumatoid arthritis.
    Attia AM; Ibrahim FA; Abd El-Latif NA; Aziz SW; Elwan AM; Abdel Aziz AA; Elgendy A; Elgengehy FT
    Lasers Surg Med; 2016 Jul; 48(5):490-7. PubMed ID: 26875769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum level of reactive oxygen metabolites (ROM) at 12 weeks of treatment with biologic agents for rheumatoid arthritis is a novel predictor for 52-week remission.
    Nakajima A; Aoki Y; Sonobe M; Takahashi H; Saito M; Nakagawa K
    Clin Rheumatol; 2017 Feb; 36(2):309-315. PubMed ID: 27858176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.